CHARLOTTE, N.C., Feb. 4, 2019 /PRNewswire/ -- NN, Inc., (Nasdaq: NNBR) ("NN" or "the Company"), announced today that its NN Life Sciences group will exhibit at the 2019 Medical Design & Manufacturing West (MD&M) show, held February 5-7 in Anaheim, California.
MD&M West is the world's largest medical design and manufacturing event. The three-day conference highlights cutting-edge technologies, while providing industry leaders with the education and connections needed to advance in the global medical manufacturing community.
NN Life Sciences, a business group of NN, Inc., partners with clients to provide end-to-end engineered solutions. With a focus on innovation, NN Life Sciences applies its world-class quality to the design, validation, and advanced manufacturing of cases and trays, reusable and single-use surgical instruments, implantable components, and drug delivery devices.
"Our comprehensive portfolio of engineered solutions highlights the company's continued ability to evolve to meet changing market needs," said Robbie Atkinson, Executive Vice President of NN Life Sciences. "Precision and innovation are core commitments of our business and we are excited to showcase these capabilities at MD&M West."
NN Life Sciences continues to transform the product lifecycle from development to distribution. The company has leveraged technology innovation and medical expertise to produce engineered solutions that optimize patient outcomes.
Visit NN Life Sciences at Booth 568 for more information.
To learn more about Life Sciences, please visit www.nninc.com and follow NN, Inc. on LinkedIn.
NN, Inc., a diversified industrial company combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of international markets. Headquartered in Charlotte, North Carolina, NN has 51 facilities in North America, Western Europe, Eastern Europe, South America, and China.
Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. (the "Company") and its subsidiaries to differ materially from those expressed or implied by this discussion. All forward-looking information is provided by the Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "assumptions", "target", "guidance", "outlook", "plans", "projection", "may", "will", "would", "expect", "intend", "estimate", "anticipate", "believe", "potential" or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. Factors which could materially affect actual results include, but are not limited to: general economic conditions and economic conditions in the industrial sector, inventory levels, regulatory compliance costs and the Company's ability to manage these costs, start-up costs for new operations, debt reduction, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with international trade, the Company's dependence on certain major customers, and the successful implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding pending and completed transactions are also forward looking statements, including statements relating to the future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company's future business and operations and the ability of the Company to successfully integrate recently acquired businesses or the possibility that the Company will be unable to execute on the intended redeployment of proceeds from a divestiture, whether due to a lack of favorable investment opportunities or otherwise.
For additional information concerning such risk factors and cautionary statements, please see the section titled "Risk Factors" in the Company's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements make in this press release, whether as a result of new information, future events or otherwise.